Feed CASBF
CA
CanSino Biologics Inc. CASBF · OTC
$3.41 +0.00% (+$0.00)
Depth
- Market cap
- ¥7.92B
- Enterprise value
- ¥7.72B
- P/E
- 266.4x
- Forward P/E
- 98.8x
- PEG
- -
- P/S
- 6.3x
- P/FCF
- -
- EV/EBITDA
- 178.1x
- ROIC
- -0.7%
- Gross margin
- 72.0%
- Net margin
- 2.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -4.6x
- Beta
- 1.16
- Free float
- 48.6%
Sector
Healthcare
Industry
Biotechnology
CEO
Xue Feng Yu
Employees
1,134
Headquarters
Tianjin
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue growth is slowing: 0.0% a year over the last 3 years against 111% over 5 years.
- What to watch: It missed profit estimates 5 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: It reports a profit, yet spends more cash than it brings in.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: ¥1.13B against ¥929.2M.
- What speaks for it: It passes 9 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number